Big pharma is backing into gene therapies to be positioned because it’s as close to a “cure” as you will get .... it’s not about future earnings per se - but if it comes through it’s not about taking a bit of the market - it takes all of the market.
Big pharma is backing into gene therapies to be positioned...
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.0¢ |
Change
0.003(3.90%) |
Mkt cap ! $74.82M | |||
| Open | High | Low | Value | Volume |
| 7.9¢ | 8.3¢ | 7.9¢ | $110.5K | 1.369M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 21322 | 8.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.2¢ | 169303 | 3 |
View Market Depth
| Last trade - 15.26pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
8.0¢ |
Change
0.003 ( 3.90 %) |
||||
| Open | High | Low | Volume | ||
| 7.9¢ | 8.3¢ | 7.9¢ | 101673 | ||
| Last updated 15.45pm 08/05/2024 ? | |||||
| PER (ASX) Chart |